SLC22A7
Solute carrier family 22 member 7
Also known as: NLT, OAT2, S22A7_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y694
- Gene
- SLC22A7
- Ensembl
- ENSG00000137204
- Chromosome
- 6
- Canonical length
- 548 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
The protein encoded by this gene is involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and appears to be localized to the basolateral membrane of the kidney. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
548 residues, UniProt reviewed canonical sequence.
>Q9Y694|SLC22A7
1 MGFEELLEQV GGFGPFQLRN VALLALPRVL LPLHFLLPIF LAAVPAHRCA LPGAPANFSH
61 QDVWLEAHLP REPDGTLSSC LRFAYPQALP NTTLGEERQS RGELEDEPAT VPCSQGWEYD
121 HSEFSSTIAT ESQWDLVCEQ KGLNRAASTF FFAGVLVGAV AFGYLSDRFG RRRLLLVAYV
181 STLVLGLASA ASVSYVMFAI TRTLTGSALA GFTIIVMPLE LEWLDVEHRT VAGVLSSTFW
241 TGGVMLLALV GYLIRDWRWL LLAVTLPCAP GILSLWWVPE SARWLLTQGH VKEAHRYLLH
301 CARLNGRPVC EDSFSQEAVS KVAAGERVVR RPSYLDLFRT PRLRHISLCC VVVWFGVNFS
361 YYGLSLDVSG LGLNVYQTQL LFGAVELPSK LLVYLSVRYA GRRLTQAGTL LGTALAFGTR
421 LLVSSDMKSW STVLAVMGKA FSEAAFTTAY LFTSELYPTV LRQTGMGLTA LVGRLGGSLA
481 PLAALLDGVW LSLPKLTYGG IALLAAGTAL LLPETRQAQL PETIQDVERK SAPTSLQEEE
541 MPMKQVQNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC22A7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 419 nTPM
Expression across tissuesHPA
Tissue
- liver: 419 nTPM
- kidney: 44 nTPM
- testis: 0.7 nTPM
- cerebellum: 0.6 nTPM
- duodenum: 0.4 nTPM
- heart muscle: 0.4 nTPM
Single-cell type
- hepatocytes: 353 nCPM
- proximal tubule cells: 118 nCPM
- cardiomyocytes: 13 nCPM
- retinal bipolar cells: 3.8 nCPM
- renal connecting tubule cells: 2.7 nCPM
- distal convoluted tubule cells: 2.6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 5.3 nTPM
- cerebral cortex: 3.4 nTPM
- basal ganglia: 3.1 nTPM
- amygdala: 2.8 nTPM
- hippocampal formation: 2.4 nTPM
- white matter: 2.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.05
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.17
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alpha-ketoglutarate transport
- monoatomic ion transport
- organic anion transport
- prostaglandin transport
- xenobiotic metabolic process
Molecular functions
- alpha-ketoglutarate transmembrane transporter activity
- organic anion transmembrane transporter activity
- prostaglandin transmembrane transporter activity
- sodium-independent organic anion transmembrane transporter activity
- transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC22A7 as an antibody target. Whether an autoantibody or antibody against SLC22A7 could matter depends on whether native SLC22A7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC22A7 is annotated at the cell surface, where native SLC22A7 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC22A7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...